Microvast Investors Face September 21 Deadline in Securities Fraud Suit

The litigation alleges that Microvast executives issued false or misleading statements regarding the company's financial health during the defined class period. Specifically, the complaint claims the firm overstated its ability to meet margin targets, citing inventory mismanagement and delays in commercial vehicle rollouts. Furthermore, the lawsuit contends that the company misled shareholders about the timeline for completing the Huzhou Phase 3.2 expansion, which was projected for completion by the end of 2025.

Investors who purchased shares during this window may be eligible for compensation under a contingency fee arrangement. While a lawsuit is already active, no class has been certified, meaning investors are not currently represented by counsel unless they retain their own. Those interested in participating or seeking lead plaintiff status can contact Phillip Kim at the Rosen Law Firm. Legal representatives emphasize that serving as a lead plaintiff is optional, and individual investors may choose to remain absent members of the class without impacting their ability to share in potential future recoveries.